This story incorporates reporting fromdevdiscourse, WJON and KIMT.Novo Nordisk has settled a lawsuit with Minnesota, agreeing ...

Novo Nordisk agreed to cap insulin prices to settle a lawsuit in which Minnesota's attorney general accused the three largest ...

Novo Nordisk has agreed to a legal settlement capping insulin prices, following Minnesota's attorney general's accusations of ...

Minnesota Attorney General Keith Ellison is expected to announce a "major development" in the litigation against three large ...

PetVivo Board Appoints Eldred as Executive Director to Lead Company Product Commercialization and Operations MINNEAPOLIS, MN, Jan. 27, 2025 ...

Janney Montgomery Scott LLC increased its stake in shares of Sanofi (NASDAQ:SNY – Free Report) by 5.9% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange ...

Sanofi's SNY +1.27% + Free Alerts short percent of float has risen 11.76% since its last report. The company recently ...

J.P. Morgan analyst Richard Vosser maintained a Hold rating on Sanofi (SNYNF – Research Report) today and set a price target of €105.00. The ...

The U.S. Food and Drug Administration has warned the pharmaceutical company Sanofi about significant deviations from Current ...

Sanofi (NASDAQ:SNY) said that a Phase 3 study of its new subcutaneous formulation of Sarclisa in the treatment of multiple myeloma met its co-primary endpoints, demonstrating non-inferiority to ...

Also Read: Sanofi’s 340B Credit Proposal Draws Federal Warning For Statutory Violation Key secondary endpoints were also achieved, including very good partial response, the incidence rate of ...

Sanofi’s SNY stock has declined 10.2% in the past three months. However, a lot of this price decline was due to the downtrend of the overall drug and biotech sector, which performed poorly in ...